Literature DB >> 22128393

Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis.

David Arnold1, Alan Girling, Andrew Stevens, Richard Lilford.   

Abstract

BACKGROUND AND
OBJECTIVE: Utilities (values representing preferences) for healthcare priority setting are typically obtained indirectly by asking patients to fill in a quality of life questionnaire and then converting the results to a utility using population values. We compared such utilities with those obtained directly from patients or the public.
DESIGN: Review of studies providing both a direct and indirect utility estimate. SELECTION CRITERIA: Papers reporting comparisons of utilities obtained directly (standard gamble or time tradeoff) or indirectly (European quality of life 5D [EQ-5D], short form 6D [SF-6D], or health utilities index [HUI]) from the same patient. DATA SOURCES: PubMed and Tufts database of utilities. STATISTICAL
METHODS: Sign test for paired comparisons between direct and indirect utilities; least squares regression to describe average relations between the different methods. MAIN OUTCOME MEASURES: Mean utility scores (or median if means unavailable) for each method, and differences in mean (median) scores between direct and indirect methods.
RESULTS: We found 32 studies yielding 83 instances where direct and indirect methods could be compared for health states experienced by adults. The direct methods used were standard gamble in 57 cases and time trade off in 60(34 used both); the indirect methods were EQ-5D (67 cases), SF-6D (13), HUI-2 (5), and HUI-3 (37). Mean utility values were 0.81 (standard gamble) and 0.77 (time tradeoff) for the direct methods; for the indirect methods: 0.59(EQ-5D), 0.63 (SF-6D), 0.75 (HUI-2) and 0.68 (HUI-3). DISCUSSION: Direct methods of estimating utilities tend to result in higher health ratings than the more widely used indirect methods, and the difference can be substantial.Use of indirect methods could have important implications for decisions about resource allocation: for example, non-lifesaving treatments are relatively more favoured in comparison with lifesaving interventions than when using direct methods.

Entities:  

Mesh:

Year:  2009        PMID: 22128393     DOI: 10.1136/bmj.b2688

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  53 in total

1.  Estimating utilities for chronic kidney disease, using SF-36 and SF-12-based measures: challenges in a population of veterans with diabetes.

Authors:  Mangala Rajan; Kuan-Chi Lai; Chin-Lin Tseng; Shirley Qian; Alfredo Selim; Lewis Kazis; Leonard Pogach; Anushua Sinha
Journal:  Qual Life Res       Date:  2012-03-06       Impact factor: 4.147

2.  Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists.

Authors:  Richard Edlin; Jeff Round; Claire Hulme; Christopher McCabe
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

3.  Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.

Authors:  Nathaniel Hendrix; David D Kim; Krishna S Patel; Beth Devine
Journal:  Med Decis Making       Date:  2021-01-15       Impact factor: 2.583

4.  The use of pharmacoeconomic evidence to support formulary decision making in Saudi Arabia: Methodological recommendations.

Authors:  Sinaa A Al Aqeel; Mohammed Al-Sultan
Journal:  Saudi Pharm J       Date:  2011-12-24       Impact factor: 4.330

5.  Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer.

Authors:  V Valentí; J Ramos; C Pérez; L Capdevila; I Ruiz; L Tikhomirova; M Sánchez; I Juez; M Llobera; E Sopena; J Rubió; R Salazar
Journal:  Clin Transl Oncol       Date:  2019-09-26       Impact factor: 3.405

6.  Mapping EORTC-QLQ-C30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients.

Authors:  Hosein Ameri; Mahmood Yousefi; Mehdi Yaseri; Azin Nahvijou; Mohammad Arab; Ali Akbari Sari
Journal:  J Gastrointest Cancer       Date:  2020-03

7.  A systematic review of utility values in children with cerebral palsy.

Authors:  Utsana Tonmukayakul; Long Khanh-Dao Le; Shalika Bohingamu Mudiyanselage; Lidia Engel; Jessica Bucholc; Brendan Mulhern; Rob Carter; Cathrine Mihalopoulos
Journal:  Qual Life Res       Date:  2018-08-02       Impact factor: 4.147

8.  EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.

Authors:  Hiten Naik; Doris Howell; Susie Su; Xin Qiu; M Catherine Brown; Ashlee Vennettilli; Margaret Irwin; Vivien Pat; Hannah Solomon; Tian Wang; Henrique Hon; Lawson Eng; Mary Mahler; Henry Thai; Valerie Ho; Wei Xu; Soo Jin Seung; Nicole Mittmann; Geoffrey Liu
Journal:  Patient       Date:  2017-02       Impact factor: 3.883

9.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

Authors:  Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman
Journal:  Addiction       Date:  2015-12-17       Impact factor: 6.526

Review 10.  The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.

Authors:  Michael Sonntag; Hans-Helmut König; Alexander Konnopka
Journal:  Pharmacoeconomics       Date:  2013-12       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.